{"id":"https://openalex.org/W4200375390","doi":"https://doi.org/10.1182/blood-2021-147623","title":"Single-Cell RNA-Sequencing Identifies Immune Biomarkers of Response to Immunotherapy in Patients with High-Risk Smoldering Myeloma","display_name":"Single-Cell RNA-Sequencing Identifies Immune Biomarkers of Response to Immunotherapy in Patients with High-Risk Smoldering Myeloma","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W4200375390","doi":"https://doi.org/10.1182/blood-2021-147623"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-147623","doi":"https://doi.org/10.1182/blood-2021-147623","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-147623","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066919686","display_name":"Romanos Sklavenitis\u2010Pistofidis","orcid":"https://orcid.org/0000-0002-8025-9850","observed_orcids":["https://orcid.org/0000-0002-8025-9850"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Romanos Sklavenitis-Pistofidis","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA","Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA","Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059227267","display_name":"Ankit K. Dutta","orcid":"https://orcid.org/0000-0003-2535-3729","observed_orcids":["https://orcid.org/0000-0003-2535-3729"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankit K. Dutta","raw_affiliation_strings":["Broad Institute of MIT & Harvard, Cambridge, MA","Harvard Medical School, Boston, MA","Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT & Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044705025","display_name":"Sylvia Ujwary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sylvia Ujwary","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015287155","display_name":"Robert Allyn Redd","orcid":"https://orcid.org/0000-0002-1329-5288","observed_orcids":["https://orcid.org/0000-0002-1329-5288"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Redd","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113981016","display_name":"Alexandra Savell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Savell","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089358613","display_name":"L\u00e9a Fl\u00e9chon","orcid":"https://orcid.org/0000-0003-4140-475X","observed_orcids":["https://orcid.org/0000-0003-4140-475X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4387152542","display_name":"CANTHER - H\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9, Plasticit\u00e9 et R\u00e9sistance aux Th\u00e9rapies des Cancers","ror":"https://ror.org/05x9zmx47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210131356","https://openalex.org/I4210141925","https://openalex.org/I4387152542"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L\u00e9a Fl\u00e9chon","raw_affiliation_strings":["University of Lille, INSERM UMRS1277, CNRS UMR9020, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Lille, INSERM UMRS1277, CNRS UMR9020, Lille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I4387152542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076120149","display_name":"Fran\u00e7ois Aguet","orcid":"https://orcid.org/0000-0001-9414-300X","observed_orcids":["https://orcid.org/0000-0001-9414-300X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Aguet","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064519985","display_name":"Nicholas J. Haradhvala","orcid":"https://orcid.org/0000-0003-1113-3135","observed_orcids":["https://orcid.org/0000-0003-1113-3135"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Haradhvala","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110678896","display_name":"Oksana Zavidij","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oksana Zavidij","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003087873","display_name":"Mark W. Bustoros","orcid":"https://orcid.org/0000-0002-4652-5449","observed_orcids":["https://orcid.org/0000-0002-4652-5449"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Bustoros","raw_affiliation_strings":["Broad Institute of MIT & Harvard, Cambridge, MA","Division of Hematology & Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY","Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT & Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Division of Hematology & Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010424289","display_name":"Sabrin Tahri","orcid":"https://orcid.org/0000-0001-8616-6607","observed_orcids":["https://orcid.org/0000-0001-8616-6607"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrin Tahri","raw_affiliation_strings":["Broad Institute of MIT & Harvard, Cambridge, MA","Harvard Medical School, Boston, MA","Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT & Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054484092","display_name":"Tarek H. Mouhieddine","orcid":"https://orcid.org/0000-0002-1190-5978","observed_orcids":["https://orcid.org/0000-0002-1190-5978"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarek H Mouhieddine","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA","Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","Harvard Medical School, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School, Cambridge, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020163280","display_name":"Nang Kham Su","orcid":"https://orcid.org/0000-0003-2875-6590","observed_orcids":["https://orcid.org/0000-0003-2875-6590"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nang K. Su","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068210248","display_name":"Lily Ardente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lily Ardente","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057261462","display_name":"Shankara K. Anand","orcid":"https://orcid.org/0000-0003-4514-0835","observed_orcids":["https://orcid.org/0000-0003-4514-0835"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shankara Anand","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034791164","display_name":"Jeffrey A. Zonder","orcid":"https://orcid.org/0000-0002-1741-2795","observed_orcids":["https://orcid.org/0000-0002-1741-2795"]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Zonder","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Research Institute, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Research Institute, Detroit, MI","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014505996","display_name":"James J. Vredenburgh","orcid":"https://orcid.org/0000-0002-2935-6057","observed_orcids":["https://orcid.org/0000-0002-2935-6057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Vredenburgh","raw_affiliation_strings":["St. Francis Hospital, Avon, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Francis Hospital, Avon, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069306856","display_name":"Adam M. Boruchov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Boruchov","raw_affiliation_strings":["St. Francis Hospital, Avon, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Francis Hospital, Avon, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045179755","display_name":"Manisha Bhutani","orcid":"https://orcid.org/0000-0002-9019-7438","observed_orcids":["https://orcid.org/0000-0002-9019-7438"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manisha Bhutani","raw_affiliation_strings":["Levine L. Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine L. Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009378735","display_name":"Saad Z. Usmani","orcid":"https://orcid.org/0000-0002-5484-8731","observed_orcids":["https://orcid.org/0000-0002-5484-8731"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saad Z. Usmani","raw_affiliation_strings":["Levine L. Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine L. Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947413","display_name":"Jeffrey Matous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey V. Matous","raw_affiliation_strings":["Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055089118","display_name":"Andrew Jenho Yee","orcid":"https://orcid.org/0000-0003-3623-7491","observed_orcids":["https://orcid.org/0000-0003-3623-7491"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Yee","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057911528","display_name":"Andrzej J. Jakubowiak","orcid":"https://orcid.org/0000-0002-2597-6822","observed_orcids":["https://orcid.org/0000-0002-2597-6822"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrzej Jakubowiak","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088396920","display_name":"Claudia E. Paba\u2010Prada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia E. Paba-Prada","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007131903","display_name":"Julia Prescott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Prescott","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049711954","display_name":"Jacob P. Laubach","orcid":"https://orcid.org/0000-0001-7565-2052","observed_orcids":["https://orcid.org/0000-0001-7565-2052"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob P. Laubach","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036677725","display_name":"Salomon Manier","orcid":"https://orcid.org/0000-0001-7653-711X","observed_orcids":["https://orcid.org/0000-0001-7653-711X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4387152542","display_name":"CANTHER - H\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9, Plasticit\u00e9 et R\u00e9sistance aux Th\u00e9rapies des Cancers","ror":"https://ror.org/05x9zmx47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210131356","https://openalex.org/I4210141925","https://openalex.org/I4387152542"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Salomon Manier","raw_affiliation_strings":["Service des Maladies du Sang, CHU Lille, Lille, France","University of Lille, INSERM UMRS1277, CNRS UMR9020, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Maladies du Sang, CHU Lille, Lille, France","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"University of Lille, INSERM UMRS1277, CNRS UMR9020, Lille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I4387152542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052163068","display_name":"Omar Nadeem","orcid":"https://orcid.org/0000-0002-4124-4277","observed_orcids":["https://orcid.org/0000-0002-4124-4277"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omar Nadeem","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064710410","display_name":"Ashraf Z. Badros","orcid":"https://orcid.org/0000-0003-1690-0188","observed_orcids":["https://orcid.org/0000-0003-1690-0188"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashraf Z. Badros","raw_affiliation_strings":["School of Medicine, University of Maryland Baltimore, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Maryland Baltimore, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075153453","display_name":"Lorenzo Trippa","orcid":"https://orcid.org/0000-0001-5218-5666","observed_orcids":["https://orcid.org/0000-0001-5218-5666"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorenzo Trippa","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029159537","display_name":"Mar\u00eda\u2010Victoria Mateos","orcid":"https://orcid.org/0000-0003-2390-1218","observed_orcids":["https://orcid.org/0000-0003-2390-1218"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":null,"type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria-Victoria Mateos","raw_affiliation_strings":["Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392592","display_name":"Gad A. Getz","orcid":"https://orcid.org/0000-0002-0936-0753","observed_orcids":["https://orcid.org/0000-0002-0936-0753"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gad Getz","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA","Center for Cancer Research, Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Center for Cancer Research, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023152679","display_name":"Irene M. Ghobrial","orcid":"https://orcid.org/0000-0001-7361-3092","observed_orcids":["https://orcid.org/0000-0001-7361-3092"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene M. Ghobrial","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA","Harvard Medical School, Boston, MA","Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"330","last_page":"330"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/high-risk-smoldering-myeloma","display_name":"high-risk smoldering myeloma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/immunotherapy-response-biomarkers","display_name":"immunotherapy response biomarkers","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.9369999766349792},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.9459999799728394},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.515999972820282},{"id":"https://openalex.org/keywords/klf2","display_name":"KLF2","score":0.765999972820282},{"id":"https://openalex.org/keywords/immunoparesis","display_name":"immunoparesis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.859000027179718},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/elotuzumab","display_name":"elotuzumab","score":0.7250000238418579},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6583895683288574},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5939375162124634},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5681844353675842},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.5042909383773804},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.4920646548271179},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43340104818344116},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40286096930503845},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36340922117233276},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34342730045318604},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.29831308126449585},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17591339349746704},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1266750693321228}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-147623","doi":"https://doi.org/10.1182/blood-2021-147623","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-147623","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7599999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104844017","https://openalex.org/W2055453275","https://openalex.org/W2169578156","https://openalex.org/W3028759878","https://openalex.org/W1966942554","https://openalex.org/W2021590138","https://openalex.org/W3213147857","https://openalex.org/W4384199128","https://openalex.org/W4386895363","https://openalex.org/W2146775426"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Patients":[2],"with":[3,76,178,184,241,278,290,431,493],"Smoldering":[4],"Multiple":[5,15],"Myeloma":[6,16],"(SMM)":[7],"are":[8,239,429],"typically":[9],"observed":[10,355],"until":[11],"progression":[12],"to":[13,33,57,91,102,131,364,367,385,443,544,560,596,607],"overt":[14],"(MM),":[17],"but":[18,42],"early":[19,394,603],"treatment":[20,156],"of":[21,40,46,73,85,100,155,181,187,208,217,258,281,293,351,402,413,420,441,473,484,491,542,552,563,574,654,692,814,825,836,847,858,869,880,891,902,915,933,948,962,980,994,1008,1022,1040,1121,1136,1148,1161,1177,1189,1201,1213,1225,1241],"high-risk":[22,77,194],"patients":[23,36,75,183,249,332,387,457,492],"may":[24,304,358,383,438,446,488,525,568,600],"improve":[25,53,439,489,610],"outcomes.":[26,612],"Clinical":[27],"and":[28,88,98,153,159,171,201,221,237,263,286,406,512,523,540,546,582,609],"genomic":[29],"biomarkers":[30,93,437,535],"can":[31,51,318],"help":[32,384],"identify":[34,386],"SMM":[35,78,192,195,248],"at":[37,144,168,329,348,411,463,486],"high":[38],"risk":[39],"progression,":[41],"whether":[43],"parallel":[44],"profiling":[45,520],"the":[47,109,120,284,291,324,352,360,368,373,391,400,471,474,508,561,592],"tumor":[48,453,580],"immune":[49,68,326,334,361,369,381,459,475,519,534,583],"microenvironment":[50],"further":[52],"our":[54,179,261,268],"models":[55],"remains":[56],"be":[58,266,319,448,504,526],"determined.":[59],"Methods":[60],"We":[61,174,212,311],"performed":[62],"single-cell":[63],"RNA":[64],"sequencing":[65],"on":[66,650,688,810,821,832,843,854,865,876,887,898,911,929,944,958,976,990,1004,1018,1036,1117,1132,1144,1157,1173,1185,1197,1209,1221,1237,1249],"CD138-":[67,138],"cells":[69,405],"from":[70,393,602],"40":[71],"samples":[72,142,166],"14":[74],"enrolled":[79],"in":[80,247,260,283,316,356,506,555,570,591],"a":[81,206,255,421,548,571,622],"Phase":[82],"II":[83],"trial":[84],"Elotuzumab,":[86],"Lenalidomide,":[87],"Dexamethasone":[89],"(NCT02279394),":[90],"develop":[92],"for":[94,521,536],"optimal":[95,537],"patient":[96,538,611],"selection":[97,539],"monitoring":[99,440,524],"response":[101,442,543,606],"treatment.":[103,251,395],"This":[104,344],"study":[105,530],"was":[106,461],"approved":[107],"by":[108,128,233,321,372,426,451],"Dana-Farber":[110],"Cancer":[111],"Institute's":[112],"Institutional":[113],"Review":[114],"Board":[115,653,691,813,824,835,846,857,868,879,890,901,914,932,947,961,979,993,1007,1021,1039,1120,1135,1147,1160,1176,1188,1200,1212,1224,1240,1252],"(#14-338).":[116],"Specifically,":[117],"we":[118,271,302,376,397,498],"used":[119],"Chromium":[121],"Single":[122],"Cell":[123],"3'":[124],"Gene":[125],"Expression":[126],"system":[127],"10X":[129],"Genomics":[130],"profile":[132,460],"33":[133],"magnetically":[134],"sorted":[135],"(Miltenyi":[136],"Biotec)":[137],"bone":[139],"marrow":[140,593],"(BM)":[141],"collected":[143,167],"baseline":[145,169],"(n=11),":[146],"cycle":[147],"9":[148],"day":[149],"1":[150],"(C9D1,":[151],"n=13),":[152],"end":[154],"(EOT,":[157],"n=9),":[158],"7":[160],"peripheral":[161,510],"blood":[162,511],"mononuclear":[163],"cell":[164],"(PBMC)":[165],"(n=4)":[170],"C9D1":[172,412],"(n=3).":[173],"integrated":[175],"this":[176],"data":[177],"cohort":[180,262],"non-trial":[182],"Monoclonal":[185],"Gammopathy":[186],"Undetermined":[188],"Significance":[189],"(n=5),":[190],"low-risk":[191],"(n=3),":[193],"(n=8),":[196],"newly":[197],"diagnosed":[198],"MM":[199],"(n=9)":[200],"healthy":[202],"donors":[203],"(n=10),":[204],"reaching":[205],"total":[207],"75":[209],"samples.":[210],"Results":[211],"found":[213,312,398,499],"that":[214,273,313,347,399,500,516,577],"higher":[215,418],"abundance":[216,317],"mature":[218],"B-cells,":[219],"Th17,":[220],"Granzyme":[222],"K":[223],"(GZMK)+":[224],"T-cells,":[225],"as":[226,228,415,417,585,587],"well":[227,416,586],"gene":[229,422],"expression":[230,423],"signatures":[231],"marked":[232,425],"type":[234],"17":[235],"genes":[236],"GZMK,":[238],"associated":[240,277,289,430],"significantly":[242,340,432,478],"longer":[243,341,479],"progression-free":[244],"survival":[245],"(PFS)":[246],"under":[250],"Although":[252],"immunoparesis":[253,274],"is":[254,275,287,328,336],"significant":[256],"predictor":[257],"PFS":[259,342,434,481],"could":[264,503,558],"thus":[265],"confounding":[267],"B-cell":[269,553],"signal,":[270],"showed":[272],"not":[276,337,447],"lower":[279],"number":[280],"B-cells":[282],"BM":[285],"instead":[288],"upregulation":[292],"transcription":[294],"factor":[295],"Kruppel-like":[296],"Factor":[297],"2":[298],"(KLF2,":[299],"q=2e-05),":[300],"which":[301,375,445,557],"hypothesize":[303],"oppose":[305],"differentiation":[306],"into":[307],"antibody-secreting":[308],"plasma":[309],"cells.":[310],"these":[314],"differences":[315],"summarized":[320],"how":[322],"normal-like":[323,338,462],"patients'":[325,509],"composition":[327,335],"baseline,":[330],"whereby":[331],"whose":[333,458],"have":[339],"(p=0.031).":[343],"model":[345],"suggests":[346],"least":[349],"some":[350],"compositional":[353],"changes":[354],"disease":[357],"reflect":[359],"system's":[362],"capacity":[363],"react":[365],"successfully":[366],"challenge":[370],"posed":[371],"tumor,":[374],"termed":[377],"'immune":[378],"reactivity'.":[379],"Baseline":[380],"reactivity":[382],"who":[388,599],"will":[389],"benefit":[390,601],"most":[392],"Furthermore,":[396],"expansion":[401],"tissue-resident":[403],"NK":[404],"exhausted":[407],"GZMK+":[408],"CD8+":[409],"T-cells":[410],"treatment,":[414,604],"levels":[419],"signature":[424],"amphiregulin":[427],"(AREG),":[428],"shorter":[433],"(p=0.039).":[435],"These":[436],"immunotherapy,":[444,608],"fully":[449],"explained":[450],"residual":[452,495],"burden":[454],"alone.":[455],"Lastly,":[456],"EOT":[464,487],"(Post-therapy":[465],"Immune":[466],"Normalization,":[467],"PIN),":[468],"potentially":[469],"signifying":[470],"resolution":[472],"challenge,":[476],"had":[477],"biochemical":[480],"(p=0.04).":[482],"Assessment":[483],"PIN":[485],"stratification":[490],"minimal":[494],"disease.":[496],"Importantly,":[497],"biomarker":[501],"status":[502],"assessed":[505],"both":[507,579],"their":[513],"BM,":[514],"suggesting":[515],"minimally":[517],"invasive":[518],"prognostication":[522],"feasible.":[527],"Conclusions":[528],"Our":[529,566],"has":[531],"nominated":[532],"novel":[533,564],"assessment":[541],"immunotherapy":[545],"uncovered":[547],"previously":[549],"unappreciated":[550],"mechanism":[551],"immunosuppression":[554],"MM,":[556],"lead":[559],"development":[562],"therapeutics.":[565],"findings":[567],"usher":[569],"next":[572],"generation":[573],"clinical":[575,589],"assays":[576],"assess":[578],"biology":[581],"state,":[584],"common":[588],"biomarkers,":[590],"or":[594,656,694,816,827,838,849,860,871,882,893,904,917,935,950,964,982,996,1010,1024,1042,1123,1138,1150,1163,1179,1191,1203,1215,1227,1243],"blood,":[595],"accurately":[597],"predict":[598],"monitor":[605],"Disclosures":[613],"Dutta:":[614],"Menarini":[615],"Silicon":[616],"Biosystems:":[617],"Consultancy.":[618,625,698,806,1059],"Haradhvala:":[619],"Constellation":[620,627],"Pharmaceuticals":[621],"MorphoSys":[623],"Company:":[624],"Zavidij:":[626],"Pharmaceuticals:":[628,1096],"Current":[629],"Employment.":[630],"Bustoros:":[631],"Janssen,":[632,700],"Bristol":[633,787,924,1052,1232],"Myers":[634,788,925,1233],"Squibb:":[635,777,789,926,1054,1234],"Honoraria,":[636,1115,1130,1142,1155,1171,1183,1195,1207,1219,1235,1247],"Speakers":[637,714,728,740,746,769,784],"Bureau;":[638,729,741,747,770],"Takeda:":[639,685,713,765,803,908,1056,1063,1129],"Consultancy,":[640,665,682,686,719,725,731,737,743,749,753,758,762,766,773,781,909,927,942,956,970,974,988,1002,1016,1030,1034,1064,1072,1076,1084,1097],"Honoraria.":[641],"Rosenblatt:":[642],"Attivare:":[643],"Consultancy;":[644,647,660,672,674,676,678,680,710,723,735,790,792,794,796,798,800,802,804,1049,1051,1055,1057,1062,1068,1070,1080,1082,1088,1091,1094],"Imaging":[645],"Endpoints:":[646],"Karyopharm:":[648,805,896,1058,1075],"Membership":[649,687,809,820,831,842,853,864,875,886,897,910,928,943,957,975,989,1003,1017,1035,1116,1131,1143,1156,1172,1184,1196,1208,1220,1236,1248],"an":[651,689,811,822,833,844,855,866,877,888,899,912,930,945,959,977,991,1005,1019,1037,1118,1133,1145,1158,1174,1186,1198,1210,1222,1238,1250],"entity's":[652,690,812,823,834,845,856,867,878,889,900,913,931,946,960,978,992,1006,1020,1038,1119,1134,1146,1159,1175,1187,1199,1211,1223,1239,1251],"Directors":[655,693,815,826,837,848,859,870,881,892,903,916,934,949,963,981,995,1009,1023,1041,1122,1137,1149,1162,1178,1190,1202,1214,1226,1242],"advisory":[657,695,817,828,839,850,861,872,883,894,905,918,936,951,965,983,997,1011,1025,1043,1124,1139,1151,1164,1180,1192,1204,1216,1228,1244],"committees;":[658,696,818,829,840,851,862,873,884,895,1125,1140,1152,1165,1181,1193,1205,1217,1229,1245],"Parexel:":[659],"Wolters":[661],"Kluwer":[662],"Health":[663],"Inc:":[664],"Patents":[666],"&":[667],"Royalties.":[668],"Zonder:":[669],"Caelum":[670],"Biosciences:":[671],"Intellia:":[673],"Alnylam:":[675],"Regeneron:":[677,1029,1087,1170],"Janssen:":[679,736,795,808,1015,1079,1107,1218],"BMS:":[681,863,1104],"Research":[683,707,720,726,732,738,744,750,754,759,763,767,774,778,782,920,938,953,967,971,985,999,1013,1027,1031,1045,1065,1073,1077,1085,1098,1102,1105,1108,1111],"Funding;":[684,708,721,733,751,755,760,764,775,779,921,939,954,968,972,986,1000,1014,1028,1032,1066,1074,1078,1086,1103,1106,1109],"Amgen:":[697,780,793,830,955,1141],"Bhutani:":[699],"MedImmune,":[701],"Takeda,":[702],"Celgene,":[703],"BMS,":[704,712],"Cerecor,":[705],"Celularity:":[706],"Sanofi:":[709,742,801,885,1081,1206],"Amgen,":[711],"Bureau.":[715,785],"Usmani:":[716],"Array":[717],"BioPharma:":[718],"Abbvie:":[722,852,1033],"Celgene/BMS:":[724,1071],"Funding,":[727,739,745,768,783],"GSK:":[730,797,874,973,1048,1166],"EdoPharma:":[734],"Merck:":[748],"Pharmacyclics:":[752],"Seattle":[756],"Genetics:":[757],"SkylineDX:":[761],"Janssen":[771],"Oncology:":[772],"Bristol-Myers":[776],"Yee:":[786],"Oncopeptides:":[791,1001,1083,1168,1246],"Adaptive:":[799,1050],"Jakubowiak:":[807],"Celgene:":[819],"Gracell:":[841],"committees.":[906],"Manier:":[907],"committees,":[919,937,952,966,984,998,1012,1026,1044],"Celgene":[922,1230],"-":[923,1231],"Adaptive":[940,1153],"Biotechnologies:":[941,1154],"Novartis:":[969],"Roche:":[987,1182],"Funding.":[1046,1099,1112],"Nadeem:":[1047],"Myer":[1053],"Richardson:":[1060],"GlaxoSmithKline:":[1061,1110],"AbbVie:":[1067],"AstraZeneca:":[1069],"Secura":[1089],"Bio:":[1090],"Protocol":[1092],"Intelligence:":[1093],"Jazz":[1095],"Badros:":[1100],"J&J:":[1101],"Mateos:":[1113],"Pfizer:":[1114],"Bluebird":[1126],"bio:":[1127],"Honoraria;":[1128,1167,1169],"Sea-Gen:":[1194],"o":[1253]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}